Skip to main content
Erschienen in: Immunologic Research 6/2022

18.07.2022 | Original Article

5Apal, Taql, Fokl, and Bsml polymorphisms and the susceptibility of Behcet’s disease: an updated meta-analysis

verfasst von: Mingxing Wu, Lanjiao Li, Lulu Tian, Danning Liu, Jia Jian, Yu Zhou, Yan Xu

Erschienen in: Immunologic Research | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to investigate whether the gene polymorphisms of vitamin D receptor (VDR) had a genetic effect on the susceptibility of Behcet’s disease (BD).

Material and methods

We conducted a meta-analysis emphasizing the association between the VDR gene polymorphisms and the risk of BD. The strength of the association in five genetic models was assessed by pooled odds ratios (OR) with a corresponding 95%confidence interval (CI).

Results

A total of seven independent comparisons with 478 cases and 666 healthy controls were included in this meta-analysis. The overall results suggested that a significant association between ApaI polymorphism and BD risk was found in allele comparison, recessive model, and homozygote model among total populations. Subgroup analysis indicated that a significant association of ApaI polymorphism in the development of BD existed under the allelic model among Africans, while for Caucasians, a similar link was identified in the recessive model and homozygote model. Regarding Bsml polymorphism, an obvious relationship was detected to be significant in allele comparison and recessive model in the Caucasian population. Interestingly, the Fokl variant decreased the risk of BD in Africans under five genetic models, while it increased the risk in Caucasians across the recessive model and homozygote model.

Conclusion

The results of this meta-analysis provide evidence of the link between the four widely studied polymorphisms in the VDR gene and BD, indicating a robust estimate of the genetic risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kiafar M, Faezi ST, Kasaeian A, Baghdadi A, Kakaei S, Mousavi SA, Nejadhosseinian M, Shahram F, Ghodsi SZ, Shams H, Davatchi F. Diagnosis of Behcet’s disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol. 2021;5(1):2.CrossRefPubMedPubMedCentral Kiafar M, Faezi ST, Kasaeian A, Baghdadi A, Kakaei S, Mousavi SA, Nejadhosseinian M, Shahram F, Ghodsi SZ, Shams H, Davatchi F. Diagnosis of Behcet’s disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol. 2021;5(1):2.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):119.CrossRefPubMed Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):119.CrossRefPubMed
3.
Zurück zum Zitat Sazzini M, Garagnani P, Sarno S, De Fanti S, Lazzano T, Yang Yao D, Boattini A, Pazzola G, Maramotti S, Boiardi L, Franceschi C, Salvarani C, Luiselli D. Tracing Behcet’s disease origins along the Silk Road: an anthropological evolutionary genetics perspective. Clin Exp Rheumatol. 2015;33(6 Suppl 94):S60-6.PubMed Sazzini M, Garagnani P, Sarno S, De Fanti S, Lazzano T, Yang Yao D, Boattini A, Pazzola G, Maramotti S, Boiardi L, Franceschi C, Salvarani C, Luiselli D. Tracing Behcet’s disease origins along the Silk Road: an anthropological evolutionary genetics perspective. Clin Exp Rheumatol. 2015;33(6 Suppl 94):S60-6.PubMed
4.
Zurück zum Zitat Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B. Behcet’s disease: from east to west. Clin Rheumatol. 2010;29(8):823–33.CrossRefPubMed Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B. Behcet’s disease: from east to west. Clin Rheumatol. 2010;29(8):823–33.CrossRefPubMed
5.
Zurück zum Zitat Tursen U, Piskin G, Lotti T, Davatchi F. Pathological and immunological developments in Behcet’s disease. Patholog Res Int. 2012;2012:305780.PubMedPubMedCentral Tursen U, Piskin G, Lotti T, Davatchi F. Pathological and immunological developments in Behcet’s disease. Patholog Res Int. 2012;2012:305780.PubMedPubMedCentral
6.
Zurück zum Zitat Mahmoudi M, Aslani S, Meguro A, Akhtari M, Fatahi Y, Mizuki N, Shahram F. A comprehensive overview on the genetics of Behcet's disease. Int Rev Immunol. 2022;41(2):84–106. Mahmoudi M, Aslani S, Meguro A, Akhtari M, Fatahi Y, Mizuki N, Shahram F. A comprehensive overview on the genetics of Behcet's disease. Int Rev Immunol. 2022;41(2):84–106.
7.
Zurück zum Zitat Muhammad JS, Ishaq M, Ahmed K. Genetics and epigenetics mechanism in the pathogenesis of Behcet’s disease. Curr Rheumatol Rev. 2019;15(1):7–13.CrossRefPubMed Muhammad JS, Ishaq M, Ahmed K. Genetics and epigenetics mechanism in the pathogenesis of Behcet’s disease. Curr Rheumatol Rev. 2019;15(1):7–13.CrossRefPubMed
8.
Zurück zum Zitat Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, Biagi E, Grassi A, Rampelli S, Silvestri E, Centanni M, Cianchi F, Gotti R, Emmi L, Brigidi P, Bizzaro N, De Bellis G, Prisco D, Candela M, D’Elios MM. Behcet’s syndrome patients exhibit specific microbiome signature. Autoimmun Rev. 2015;14(4):269–76.CrossRefPubMed Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, Biagi E, Grassi A, Rampelli S, Silvestri E, Centanni M, Cianchi F, Gotti R, Emmi L, Brigidi P, Bizzaro N, De Bellis G, Prisco D, Candela M, D’Elios MM. Behcet’s syndrome patients exhibit specific microbiome signature. Autoimmun Rev. 2015;14(4):269–76.CrossRefPubMed
9.
Zurück zum Zitat Malek Mahdavi A, Khabbazi A, Yaaghoobian B, Ghojazadeh M, Agamohammadi R, Kheyrollahiyan A, Rashtchizadeh N. Cigarette smoking and risk of Behcet’s disease: a propensity score matching analysis. Mod Rheumatol. 2019;29(4):633–9.CrossRefPubMed Malek Mahdavi A, Khabbazi A, Yaaghoobian B, Ghojazadeh M, Agamohammadi R, Kheyrollahiyan A, Rashtchizadeh N. Cigarette smoking and risk of Behcet’s disease: a propensity score matching analysis. Mod Rheumatol. 2019;29(4):633–9.CrossRefPubMed
10.
Zurück zum Zitat Faezi ST, Ansari N, Paragomi P, Akhlaghi M, Ghanavat M, Davatchi F. Vitamin D deficiency in patients with Behcet’s disease. J Diabetes Metab Disord. 2014;13(1):18.CrossRefPubMedPubMedCentral Faezi ST, Ansari N, Paragomi P, Akhlaghi M, Ghanavat M, Davatchi F. Vitamin D deficiency in patients with Behcet’s disease. J Diabetes Metab Disord. 2014;13(1):18.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Gul A. Genetics of Behcet’s disease: lessons learned from genomewide association studies. Curr Opin Rheumatol. 2014;26(1):56–63.CrossRefPubMed Gul A. Genetics of Behcet’s disease: lessons learned from genomewide association studies. Curr Opin Rheumatol. 2014;26(1):56–63.CrossRefPubMed
12.
Zurück zum Zitat Sheikh V, Kasapoglu P, Zamani A, Basiri Z, Tahamoli-Roudsari A, Alahgholi-Hajibehzad M. Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4(+) T cell cytokines and upregulate inhibitory markers. Hum Immunol. 2018;79(6):439–45.CrossRefPubMed Sheikh V, Kasapoglu P, Zamani A, Basiri Z, Tahamoli-Roudsari A, Alahgholi-Hajibehzad M. Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4(+) T cell cytokines and upregulate inhibitory markers. Hum Immunol. 2018;79(6):439–45.CrossRefPubMed
13.
Zurück zum Zitat Alireza Khabbazi MG, Hajebrahimi S, Nikniaz Z. Relationship between vitamin D level and Bechcet’s disease activity: a systematic review and meta-analysis. Int J Vitam Nutr Res. 2020;90(5–6):527–34.CrossRefPubMed Alireza Khabbazi MG, Hajebrahimi S, Nikniaz Z. Relationship between vitamin D level and Bechcet’s disease activity: a systematic review and meta-analysis. Int J Vitam Nutr Res. 2020;90(5–6):527–34.CrossRefPubMed
14.
Zurück zum Zitat Bizzaro G, Antico A, Fortunato A, Bizzaro N. Vitamin D and autoimmune diseases: is vitamin D receptor (VDR) polymorphism the culprit? Isr Med Assoc J. 2017;19(7):438–43.PubMed Bizzaro G, Antico A, Fortunato A, Bizzaro N. Vitamin D and autoimmune diseases: is vitamin D receptor (VDR) polymorphism the culprit? Isr Med Assoc J. 2017;19(7):438–43.PubMed
15.
Zurück zum Zitat Mestiri S, Zaaber I, Nasr I, Marmouch H. Implication of VDR Rs7975232 and FCGR2A Rs1801274 gene polymorphisms in the risk and the prognosis of autoimmune thyroid diseases in the Tunisian population. Balkan J Med Genet. 2020;23(1):69–76.CrossRefPubMedPubMedCentral Mestiri S, Zaaber I, Nasr I, Marmouch H. Implication of VDR Rs7975232 and FCGR2A Rs1801274 gene polymorphisms in the risk and the prognosis of autoimmune thyroid diseases in the Tunisian population. Balkan J Med Genet. 2020;23(1):69–76.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Zhang WT, Jin TF, Chen L. Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis. Lupus. 2020;29(4):364–70.CrossRefPubMed Zhang WT, Jin TF, Chen L. Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis. Lupus. 2020;29(4):364–70.CrossRefPubMed
17.
Zurück zum Zitat Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000;22(2):203–17.CrossRefPubMed Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000;22(2):203–17.CrossRefPubMed
18.
Zurück zum Zitat Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56.CrossRefPubMed Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56.CrossRefPubMed
19.
Zurück zum Zitat van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB, Overbergh L, Verstuyf A, Bouillon R, Roep BO, Badenhoop K, Mathieu C. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37(2):395–405.CrossRefPubMed van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB, Overbergh L, Verstuyf A, Bouillon R, Roep BO, Badenhoop K, Mathieu C. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37(2):395–405.CrossRefPubMed
20.
Zurück zum Zitat Karray EF, Ben Dhifallah I, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, Hamzaoui K, Zakraoui L. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behcet’s disease in Tunisians. Joint Bone Spine. 2012;79(2):144–8.CrossRefPubMed Karray EF, Ben Dhifallah I, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, Hamzaoui K, Zakraoui L. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behcet’s disease in Tunisians. Joint Bone Spine. 2012;79(2):144–8.CrossRefPubMed
21.
Zurück zum Zitat Kolahi S, Khabbazi A, Khodadadi H, Estiar MA, Hajialiloo M, Emrahi L, Sakhinia E. Vitamin D receptor gene polymorphisms in Iranian Azary patients with Behcet’s disease. Scand J Rheumatol. 2015;44(2):163–7.CrossRefPubMed Kolahi S, Khabbazi A, Khodadadi H, Estiar MA, Hajialiloo M, Emrahi L, Sakhinia E. Vitamin D receptor gene polymorphisms in Iranian Azary patients with Behcet’s disease. Scand J Rheumatol. 2015;44(2):163–7.CrossRefPubMed
22.
Zurück zum Zitat Tizaoui K, Kaabachi W, Ouled Salah M, Ben Amor A, Hamzaoui A, Hamzaoui K. Vitamin D receptor TaqI and ApaI polymorphisms: a comparative study in patients with Behcet’s disease and rheumatoid arthritis in Tunisian population. Cell Immunol. 2014;290(1):66–71.CrossRefPubMed Tizaoui K, Kaabachi W, Ouled Salah M, Ben Amor A, Hamzaoui A, Hamzaoui K. Vitamin D receptor TaqI and ApaI polymorphisms: a comparative study in patients with Behcet’s disease and rheumatoid arthritis in Tunisian population. Cell Immunol. 2014;290(1):66–71.CrossRefPubMed
23.
Zurück zum Zitat Erten G, Kalkan M, Bilgic Gazioglu S, Akdeniz N, Ozkok E, B Vural, TaqI, FokI, and ApaI polymorphisms in the vitamin D receptor in Behcet’s disease in Turkish population. Dis Markers 2016;2016 7475080. Erten G, Kalkan M, Bilgic Gazioglu S, Akdeniz N, Ozkok E, B Vural, TaqI, FokI, and ApaI polymorphisms in the vitamin D receptor in Behcet’s disease in Turkish population. Dis Markers 2016;2016 7475080.
24.
Zurück zum Zitat Kamal A, Gamal SM, Elgengehy FT, Alkemary AK, Siam I. Association of VDR ApaI and TaqI gene polymorphisms with the risk of scleroderma and Behcet’s disease. Immunol Invest. 2016;45(6):531–42.CrossRefPubMed Kamal A, Gamal SM, Elgengehy FT, Alkemary AK, Siam I. Association of VDR ApaI and TaqI gene polymorphisms with the risk of scleroderma and Behcet’s disease. Immunol Invest. 2016;45(6):531–42.CrossRefPubMed
25.
Zurück zum Zitat Zeinab Al-Nahas MF, El Menyawi M, Shaker O, Ragab G. 25-Hydroxyvitamin D3 deficiency and vitamin D receptor polymorphisms in Egyptian patients with Behçet’s disease: a pilot study. Int J Clin Rheumatol. 2017;12(2):020–7. Zeinab Al-Nahas MF, El Menyawi M, Shaker O, Ragab G. 25-Hydroxyvitamin D3 deficiency and vitamin D receptor polymorphisms in Egyptian patients with Behçet’s disease: a pilot study. Int J Clin Rheumatol. 2017;12(2):020–7.
26.
Zurück zum Zitat Dal NE, Cerci P, Olmez U, Keskin G. The role of vitamin D receptor gene polymorphisms in the pathogenesis of Behcet’s disease: a case-control study in Turkish population. Ann Hum Genet. 2019;83(3):177–86.CrossRefPubMed Dal NE, Cerci P, Olmez U, Keskin G. The role of vitamin D receptor gene polymorphisms in the pathogenesis of Behcet’s disease: a case-control study in Turkish population. Ann Hum Genet. 2019;83(3):177–86.CrossRefPubMed
27.
Zurück zum Zitat Zahra Mirfeizi ST, Ravanshad Y, Hashemzadeh K, Kharazmi E, Mehrad-Majd H. Associations between vitamin D receptor polymorphisms and susceptibility to Behcet’s disease: a meta-analysis. Immunol Invest. 2018;47(4):389–402. Zahra Mirfeizi ST, Ravanshad Y, Hashemzadeh K, Kharazmi E, Mehrad-Majd H. Associations between vitamin D receptor polymorphisms and susceptibility to Behcet’s disease: a meta-analysis. Immunol Invest. 2018;47(4):389–402.
28.
Zurück zum Zitat Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol. 2011;11:41.CrossRefPubMedPubMedCentral Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol. 2011;11:41.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991–6.CrossRefPubMed Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991–6.CrossRefPubMed
31.
Zurück zum Zitat Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119–29.CrossRefPubMed Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119–29.CrossRefPubMed
32.
Zurück zum Zitat Seydi Shirvania S. The molecular and clinical evidence of vitamin D signaling as a modulator of the immune system: role in Behçet’s disease. Immunol Lett. 2019;2019:10–9.CrossRef Seydi Shirvania S. The molecular and clinical evidence of vitamin D signaling as a modulator of the immune system: role in Behçet’s disease. Immunol Lett. 2019;2019:10–9.CrossRef
33.
Zurück zum Zitat Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids. 2013;78(2):127–36.CrossRefPubMed Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids. 2013;78(2):127–36.CrossRefPubMed
34.
Zurück zum Zitat Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis. 2009;68(3):446–7.CrossRefPubMed Cutolo M, Otsa K, Paolino S, Yprus M, Veldi T, Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis. 2009;68(3):446–7.CrossRefPubMed
35.
Zurück zum Zitat Danyal Imani BR, Motallebnezhad M, Rezae R. Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis. BMC Neurol. 2019;19(1):339.CrossRefPubMedPubMedCentral Danyal Imani BR, Motallebnezhad M, Rezae R. Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis. BMC Neurol. 2019;19(1):339.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Tizaoui K KW, Hamzaoui A. Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol. 2015;12:243–52.CrossRefPubMed Tizaoui K KW, Hamzaoui A. Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol. 2015;12:243–52.CrossRefPubMed
37.
Zurück zum Zitat Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol. 2004;89–90(1–5):187–93.CrossRefPubMed Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol. 2004;89–90(1–5):187–93.CrossRefPubMed
38.
Zurück zum Zitat Li L, Wu B, Liu JY, Yang LB. Vitamin D receptor gene polymorphisms and type 2 diabetes: a meta-analysis. Arch Med Res. 2013;44(3):235–41.CrossRefPubMed Li L, Wu B, Liu JY, Yang LB. Vitamin D receptor gene polymorphisms and type 2 diabetes: a meta-analysis. Arch Med Res. 2013;44(3):235–41.CrossRefPubMed
39.
Zurück zum Zitat Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51(7):2294–300.CrossRefPubMed Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51(7):2294–300.CrossRefPubMed
40.
Zurück zum Zitat Yun Zhang WX, Lu P, Yuan H. The association between VDR gene polymorphisms and diabetic retinopathy susceptibility: a systematic review and meta-analysis. Biomed Res Int. 2016;2016:5305282. Yun Zhang WX, Lu P, Yuan H. The association between VDR gene polymorphisms and diabetic retinopathy susceptibility: a systematic review and meta-analysis. Biomed Res Int. 2016;2016:5305282.
41.
Zurück zum Zitat Kalthoum Tizaoui KH. Association between VDR polymorphisms and rheumatoid arthritis disease: systematic review and updated meta-analysis of case-control studies. Immunobiology. 2015;220(6):807–16.CrossRefPubMed Kalthoum Tizaoui KH. Association between VDR polymorphisms and rheumatoid arthritis disease: systematic review and updated meta-analysis of case-control studies. Immunobiology. 2015;220(6):807–16.CrossRefPubMed
42.
Zurück zum Zitat Neves JSF, Visentainer JEL, Reis D, Rocha Loures MA, Alves HV, Lara-Armi FF, de Alencar JB, Valentin Zacarias JM, Sell AM. The influence of vitamin D receptor gene polymorphisms in spondyloarthritis. Int J Inflam. 2020;2020 8880879 Neves JSF, Visentainer JEL, Reis D, Rocha Loures MA, Alves HV, Lara-Armi FF, de Alencar JB, Valentin Zacarias JM, Sell AM. The influence of vitamin D receptor gene polymorphisms in spondyloarthritis. Int J Inflam. 2020;2020 8880879
43.
Metadaten
Titel
5Apal, Taql, Fokl, and Bsml polymorphisms and the susceptibility of Behcet’s disease: an updated meta-analysis
verfasst von
Mingxing Wu
Lanjiao Li
Lulu Tian
Danning Liu
Jia Jian
Yu Zhou
Yan Xu
Publikationsdatum
18.07.2022
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 6/2022
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-022-09306-8

Weitere Artikel der Ausgabe 6/2022

Immunologic Research 6/2022 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.